STLR Link Roundup – November 22, 2019

Global Blood secures FDA approval for new pill to treat sickle cell disease Global Blood Therapeutics, an international pharmaceutical company, was given an accelerated approval by the FDA, for their drug, Oxybryta. The accelerated approval means that a follow-up clinical trial will still be needed. The move was surprising: it came three months ahead of time, but more importantly, was based on a mode of showing efficacy. The FDA usually gives approval for such drugs Continue Reading →

Blockchain-based Dispute Resolution on the Kleros Platform: Trial by Jury or Arbitration?

Introduction In September 2019, Kleros, an online dispute resolution platform that utilizes blockchain technology and crowdsourcing, released the latest version of its White Paper. The Paper sets out how they aim to revolutionize dispute resolution, by bringing justice cheaply and efficiently to the masses. A glimpse at Kleros’ Twitter feed reveals an ambitious vision beyond just dispute resolution in smart contracts, into decentralized courts that theoretically could solve any dispute (FN1), and even determine whether Continue Reading →